Outcomes of Community Pharmacy Interventions on Patients with Medicines Under Additional Monitoring-Reference-Cited by-同舟云学术

Outcomes of Community Pharmacy Interventions on Patients with Medicines Under Additional Monitoring

Published:2024-07 Issue: Volume:Volume 13 Page:115-125
ISSN:2230-5254
Container-title:Integrated Pharmacy Research and Practice
language:en
Short-container-title:IPRP

Author:

Aizpurua-Arruti Xabier^ORCID,Benrimoj Shalom Charlie^ORCID,Goyenechea Estibaliz^ORCID,Isla Arantxa^ORCID,Oñatibia-Astibia Ainhoa^ORCID,Malet-Larrea Amaia^ORCID,Gastelurrutia Miguel Ángel^ORCID,Cuevas Olatz,Rodríguez-Castejón Julen^ORCID,Domingo-Echaburu Saioa^ORCID,Solinís María Ángeles^ORCID,García Montserrat^ORCID,del Pozo-Rodríguez Ana^ORCID

Publisher

Informa UK Limited

Reference44 articles.

1. Regulation (eu) no 1027/2012 of the European Parliament and of the Council of; 2012. Available from: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2012:316:0038:0040:EN:PDF. Accessed February 20, 2024.

2. European Medicines Agency. Medicines Under Additional Monitoring. Available from: https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/pharmacovigilance-post-authorisation/medicines-under-additional-monitoring. Accessed February 20, 2024.

3. Australian Government. Therapeutic Goods Administration. The Black Triangle scheme. Available from: https://www.tga.gov.au/how-we-regulate/monitoring-safety-and-shortages/report-adverse-event-or-incident/report-adverse-events-medicines-and-biologicals/black-triangle-scheme#:~:text=How%20the%20Black%20Triangle%20Scheme,Product%20Information%20(PI)%20documents. Accessed February 20, 2024.

4. UK Government. The Black Triangle Scheme. Available from: https://www.gov.uk/drug-safety-update/the-black-triangle-scheme-or#:~:text=A%20Black%20Triangle%20symbol%20is,a%20new%20route%20of%20administration. Accessed February 20, 2024.

5. European Medicines Agency. Guideline on Good Pharmacovigilance Practices Module X—Additional Monitoring; 2013. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-pharmacovigilance-practices-module-x-additional-monitoring_en.pdf. Accessed February 20, 2024.